Irinotecan hydrochloride (nano) micelles (National Center For Nanoscience And Technology)

盐酸伊立替康（纳米）胶束

Report date: 2026/05/22 20:01:29

Base Information

Drug NameIrinotecan hydrochloride (nano) micelles (National Center For Nanoscience And Technology)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsLarge intestine neoplasm
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNational Center For Nanoscience And Technology
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Pharmaceutical Research And Development Co LtdNational Center For Nanoscience And Technology
Inactive CompaniesN/A
Active IndicationsLarge intestine neoplasm
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A